checkAd

     145  0 Kommentare Saniona Receives U.S. FDA Orphan Drug Designation for Tesomet in Prader-Willi Syndrome - Seite 3

    Attachment


     

    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Saniona Receives U.S. FDA Orphan Drug Designation for Tesomet in Prader-Willi Syndrome - Seite 3 PRESS RELEASE March 3, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Tesomet for the …